UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Anthracyclines as Topoisomerase II Poisons: From Early Studies to New Perspectives

International journal of molecular sciences, 2018-11, Vol.19 (11), p.3480

2018

Volltextzugriff (PDF)

Structural Basis of Type II Topoisomerase Inhibition by the Anticancer Drug Etoposide

Science (American Association for the Advancement of Science), 2011-07, Vol.333 (6041), p.459-462

2011

Volltextzugriff (PDF)

Topoisomerase II-Induced Chromosome Breakage and Translocation Is Determined by Chromosome Architecture and Transcriptional Activity

Molecular cell, 2019-07, Vol.75 (2), p.252-266.e8

2019

Volltextzugriff (PDF)

DNA topoisomerase 1 and 2A function as oncogenes in liver cancer and may be direct targets of nitidine chloride

International journal of oncology, 2018-11, Vol.53 (5), p.1897-1912

2018

Volltextzugriff (PDF)

Recent advances in the development of dual topoisomerase I and II inhibitors as anticancer drugs

Current medicinal chemistry, 2010-12, Vol.17 (35), p.4270-4290

2010

Volltextzugriff (PDF)

Dynophore-Based Approach in Virtual Screening: A Case of Human DNA Topoisomerase IIα

International journal of molecular sciences, 2021-12, Vol.22 (24), p.13474

2021

Volltextzugriff (PDF)

Rational design, synthesis, and evaluation of novel 2,4-Chloro- and Hydroxy-Substituted diphenyl Benzofuro[3,2-b]Pyridines: Non-intercalative catalytic topoisomerase I and II dual inhibitor

European journal of medicinal chemistry, 2017-02, Vol.127, p.318-333

2017

Volltextzugriff (PDF)

Synthesis of podophyllotoxin linked β-carboline congeners as potential anticancer agents and DNA topoisomerase II inhibitors

European journal of medicinal chemistry, 2018-01, Vol.144, p.557-571

2018

Volltextzugriff (PDF)

Fluoroquinolone-gyrase-DNA complexes: two modes of drug binding

The Journal of biological chemistry, 2014-05, Vol.289 (18), p.12300-12312

2014

Volltextzugriff (PDF)

Inhibition of human topoisomerase I and II and anti-proliferative effects on MCF-7 cells by new titanocene complexes

Bioorganic & medicinal chemistry, 2015-11, Vol.23 (22), p.7302-7312

2015

Volltextzugriff (PDF)

Rational Design, Synthesis, Molecular Docking, and Biological Evaluations of New Phenylpiperazine Derivatives of 1,2-Benzothiazine as Potential Anticancer Agents

Molecules (Basel, Switzerland), 2024-09, Vol.29 (18), p.4282

2024

Volltextzugriff (PDF)

Design, synthesis and biological evaluation of novel 7-alkylamino substituted benzo[a]phenazin derivatives as dual topoisomerase I/II inhibitors

European journal of medicinal chemistry, 2015-03, Vol.92, p.540-553

2015

Volltextzugriff (PDF)

Cyanotriazoles are selective topoisomerase II poisons that rapidly cure trypanosome infections

Science (American Association for the Advancement of Science), 2023-06, Vol.380 (6652), p.1349-1356

2023

Volltextzugriff (PDF)

Synthesis and biological evaluation of novel pyrazoline derivatives containing indole skeleton as anti-cancer agents targeting topoisomerase II

European journal of medicinal chemistry, 2020-08, Vol.200, p.112459, Article 112459

2020

Volltextzugriff (PDF)

TOP2B: The First Thirty Years

International journal of molecular sciences, 2018-09, Vol.19 (9), p.2765

2018

Volltextzugriff (PDF)

Novel N-4-piperazinyl-ciprofloxacin-chalcone hybrids: Synthesis, physicochemical properties, anticancer and topoisomerase I and II inhibitory activity

European journal of medicinal chemistry, 2013-11, Vol.69, p.427-438

2013

Volltextzugriff (PDF)

Design, efficient synthesis, docking studies, and anticancer evaluation of new quinoxalines as potential intercalative Topo II inhibitors and apoptosis inducers

Bioorganic chemistry, 2020-11, Vol.104, p.104255, Article 104255

2020

Volltextzugriff (PDF)

Ginkgo biloba leaf extract induces DNA damage by inhibiting topoisomerase II activity in human hepatic cells

Scientific reports, 2015-09, Vol.5 (1), p.14633, Article 14633

2015

Volltextzugriff (PDF)

Novel indolizino[8,7-b]indole hybrids as anti-small cell lung cancer agents: Regioselective modulation of topoisomerase II inhibitory and DNA crosslinking activities

European journal of medicinal chemistry, 2017-02, Vol.127, p.235-249

2017

Volltextzugriff (PDF)

Topo II inhibition and DNA intercalation by new phthalazine-based derivatives as potent anticancer agents: design, synthesis, anti-proliferative, docking, and in vivo studies

Journal of enzyme inhibition and medicinal chemistry, 2022-12, Vol.37 (1), p.299-314

2022

Volltextzugriff (PDF)

Topoisomerase II Inhibitors and Poisons, and the Influence of Cell Cycle Checkpoints

Current medicinal chemistry, 2017-01, Vol.24 (15), p.1504

2017

Volltextzugriff (PDF)

Discovery of aminopiperidine based potent & novel topoisomerase inhibitor with broad spectrum anti-bacterial activity

Bioorganic & medicinal chemistry letters, 2024-10, Vol.111, p.129911, Article 129911

2024

Volltextzugriff (PDF)

Topoisomerase Inhibitors Addressing Fluoroquinolone Resistance in Gram-Negative Bacteria

Journal of medicinal chemistry, 2020-07, Vol.63 (14), p.7773-7816

2020

Volltextzugriff (PDF)

Design, synthesis, molecular modeling, in vivo studies and anticancer activity evaluation of new phthalazine derivatives as potential DNA intercalators and topoisomerase II inhibitors

Bioorganic chemistry, 2020-10, Vol.103, p.104233, Article 104233

2020

Volltextzugriff (PDF)

Discovery of dihydroxylated 2,4-diphenyl-6-thiophen-2-yl-pyridine as a non-intercalative DNA-binding topoisomerase II-specific catalytic inhibitor

European journal of medicinal chemistry, 2014-06, Vol.80, p.428-438

2014

Volltextzugriff (PDF)

1 – 25 von 9.738

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(8.978)
Mit Volltextzugriff
(8.203)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

10 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(7.757)
Life Sciences & Biomedicine
(7.259)
Humans
(5.518)
Dna Topoisomerases, Type Ii - Metabolism
(3.639)
Biological And Medical Sciences
(3.202)
Topoisomerase Ii Inhibitors
(2.765)
Animals
(2.733)
Biochemistry & Molecular Biology
(2.266)
Medical Sciences
(2.219)
Dna Topoisomerases, Type Ii - Genetics
(2.088)
Pharmacology & Pharmacy
(2.065)
Pharmacology. Drug Treatments
(1.727)
Oncology
(1.697)
Female
(1.501)
Antineoplastic Agents - Pharmacology
(1.295)
Antineoplastic Agents
(1.111)
Fundamental And Applied Biological Sciences. Psychology
(1.070)
Dna
(1.064)
Mice
(1.057)
Male
(989)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(9.012)
EZB Electronic Journals Library
(4.622)
IngentaConnect
(4.041)
Journals@Ovid Full Text
(2.501)
ScienceDirect
(2.153)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(1.983)
Publisher or Other Site
(1.964)
IngentaConnect Journals
(1.492)
Wiley Online Library
(1.015)
Springer journals
(811)
Wiley Online Library
(780)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(630)
Nature Journals
(412)
Taylor & Francis Journals Auto-Holdings Collection
(374)
Taylor & Francis
(362)
Oxford journals
(342)
Taylor & Francis Journals Complete
(287)
JSTOR
(282)
Oxford Journals 2020 Medicine
(226)
Nexis Uni
(205)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(22)

Menü

Weitere Dienste

Einstellungen

Anthracyclines as Topoisomerase II Poisons: From Early Studies to New Perspectives

Structural Basis of Type II Topoisomerase Inhibition by the Anticancer Drug Etoposide

Topoisomerase II-Induced Chromosome Breakage and Translocation Is Determined by Chromosome Architecture and Transcriptional Activity

DNA topoisomerase 1 and 2A function as oncogenes in liver cancer and may be direct targets of nitidine chloride

Recent advances in the development of dual topoisomerase I and II inhibitors as anticancer drugs

Dynophore-Based Approach in Virtual Screening: A Case of Human DNA Topoisomerase IIα

Rational design, synthesis, and evaluation of novel 2,4-Chloro- and Hydroxy-Substituted diphenyl Benzofuro[3,2-b]Pyridines: Non-intercalative catalytic topoisomerase I and II dual inhibitor

Synthesis of podophyllotoxin linked β-carboline congeners as potential anticancer agents and DNA topoisomerase II inhibitors

Fluoroquinolone-gyrase-DNA complexes: two modes of drug binding

Inhibition of human topoisomerase I and II and anti-proliferative effects on MCF-7 cells by new titanocene complexes

Rational Design, Synthesis, Molecular Docking, and Biological Evaluations of New Phenylpiperazine Derivatives of 1,2-Benzothiazine as Potential Anticancer Agents

Design, synthesis and biological evaluation of novel 7-alkylamino substituted benzo[a]phenazin derivatives as dual topoisomerase I/II inhibitors

Cyanotriazoles are selective topoisomerase II poisons that rapidly cure trypanosome infections

Synthesis and biological evaluation of novel pyrazoline derivatives containing indole skeleton as anti-cancer agents targeting topoisomerase II

TOP2B: The First Thirty Years

Novel N-4-piperazinyl-ciprofloxacin-chalcone hybrids: Synthesis, physicochemical properties, anticancer and topoisomerase I and II inhibitory activity

Design, efficient synthesis, docking studies, and anticancer evaluation of new quinoxalines as potential intercalative Topo II inhibitors and apoptosis inducers

Ginkgo biloba leaf extract induces DNA damage by inhibiting topoisomerase II activity in human hepatic cells

Novel indolizino[8,7-b]indole hybrids as anti-small cell lung cancer agents: Regioselective modulation of topoisomerase II inhibitory and DNA crosslinking activities

Topo II inhibition and DNA intercalation by new phthalazine-based derivatives as potent anticancer agents: design, synthesis, anti-proliferative, docking, and in vivo studies

Topoisomerase II Inhibitors and Poisons, and the Influence of Cell Cycle Checkpoints

Discovery of aminopiperidine based potent & novel topoisomerase inhibitor with broad spectrum anti-bacterial activity

Topoisomerase Inhibitors Addressing Fluoroquinolone Resistance in Gram-Negative Bacteria

Design, synthesis, molecular modeling, in vivo studies and anticancer activity evaluation of new phthalazine derivatives as potential DNA intercalators and topoisomerase II inhibitors

Discovery of dihydroxylated 2,4-diphenyl-6-thiophen-2-yl-pyridine as a non-intercalative DNA-binding topoisomerase II-specific catalytic inhibitor

Suchergebnisse filtern